EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity

Siyamthemba Dlamini, Doty Ojwach, Jennifer Giandhari, Bongiwe Ndlovu, Zaza Ndhlovu, Thumbi Ndung'u iD, Jaclyn Mann iD

Journal of Virology · 2026

DOI: 10.1128/jvi.01151-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Siyamthemba Dlamini und 6 weiteren Autor:innen. Beteiligte Einrichtung: HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South A…. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, HIV Antibodies, Genetic Variation. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poliomyelitis Research Foundation, Gilead Sciences, Alliance for Accelerating Excellence in Science in Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Broadly neutralizing antibodies (bNAbs) are a promising strategy to target the HIV-1 reservoir, the main barrier to cure. HIV-1 variants may differ in Env sequence and neutralization sensitivity across anatomical compartments. We investigated genetic differences and differences in neutralization sensitivity between Env variants persisting in peripheral blood mononuclear cell (PBMC) and lymph node (LN) reservoirs, and pre-therapy plasma variants. The study included 11 individuals on antiretroviral therapy in Durban, South Africa. Env sequences derived from pre-therapy plasma and from PBMCs and LN reservoirs were assessed for reservoir-specific genetic differences. Recombinant viruses encoding Env variants were generated for six participants and tested for neutralization sensitivity using a panel of nine clinically relevant bNAbs. We observed genetic divergence between compartments, with a median of 6 and 19 amino acid differences between pre-therapy plasma and LN and PBMC reservoirs, respectively. Of these, 63% (LN) and 73% (PBMC) were confirmed by next-generation sequencing to be unique to the reservoir, with few occurring at sites previously associated with altered bNAb sensitivity. Phenotypic analysis revealed no consistent compartment-specific patterns in neutralization sensitivity. CD4-binding site (CD4bs) and gp120–gp41 interface bNAbs showed broad coverage across compartments, while sensitivity to V2 and V3 antibodies was more variable. Although reservoir-derived Env variants show genetic divergence from pre-therapy viruses, this variation is largely not at sites reported to alter bNAb sensitivity and does not translate into consistent compartment-specific differences in bNAb sensitivity. The broad activity of CD4bs and interface-targeting bNAbs across compartments supports their suitability in antibody-based HIV cure strategies. IMPORTANCE HIV persists in reservoirs during antiretroviral therapy, preventing a cure. Broadly neutralizing antibodies (bNAbs) are a promising strategy to target these reservoirs, but it is unclear whether viruses in different tissues respond differently to these antibodies. Here, we show that although HIV variants in blood and lymph node reservoirs differ genetically from viruses present before treatment; they do not show consistent changes in antibody sensitivity. Importantly, antibodies targeting the CD4-binding site and the gp120–gp41 interface remained broadly effective across all compartments. These findings suggest that key bNAbs can target HIV reservoirs throughout different body compartments, supporting their use in cure strategies and highlighting the value of combining antibodies to overcome viral diversity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHIV AntibodiesGenetic Variationenv Gene Products, Human Immunodeficiency VirusAntibodies, NeutralizingBroadly Neutralizing AntibodiesHumansLeukocytes, MononuclearHIV Envelope Protein gp120Lymph NodesNeutralization TestsSouth Africa

Stichwörter der Autor:innen

HIV-1 envelopeHIV-1 reservoirHIV-1 subtype Cbroadly neutralizing antibodieslymph nodesneutralization assaysperipheral blood mononuclear cells

Substanzen

HIV Antibodiesenv Gene Products, Human Immunodeficiency VirusHIV Envelope Protein gp120Antibodies, NeutralizingBroadly Neutralizing Antibodies

Autor:innen und Institutionen

  • HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
  • KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa.
  • Africa Health Research Institute (AHRI), Durban, South Africa.
  • Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, USA.
  • Division of Infection and Immunity, University College London, London, United Kingdom.

ORCID-Profile: Thumbi Ndung'u, Jaclyn Mann

Förderung

  • Poliomyelitis Research Foundation
  • Gilead Sciences
  • Alliance for Accelerating Excellence in Science in Africa
  • African Academy of Sciences
  • Wellcome Trust
  • NIAID NIH HHS
  • International AIDS Vaccine Initiative
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Dlamini, S., Ojwach, D., Giandhari, J., Ndlovu, B., Ndhlovu, Z., Ndung'u, T., & Mann, J. (2026). Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity. Journal of Virology. https://doi.org/10.1128/jvi.01151-26

Vancouver

Dlamini S, Ojwach D, Giandhari J, Ndlovu B, Ndhlovu Z, Ndung'u T, et al. Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity. Journal of Virology. 2026. doi:10.1128/jvi.01151-26

BibTeX
@article{Dlamini2026,
  author = {Dlamini, Siyamthemba and Ojwach, Doty and Giandhari, Jennifer and Ndlovu, Bongiwe and Ndhlovu, Zaza and Ndung'u, Thumbi and Mann, Jaclyn},
  title = {Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01151-26}
}
Kostenlos starten →